Sponsor:
Elysium Health
Code:
NCT03635411
Conditions
Recovery of Function
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Interventions
Nicotinamide Riboside and Pterostilbene
Placebo
Brief summary:
Conditions
Recovery of Function
Study ID
NCT03635411
Start date
Dec 6, 2018
Status verified date
Jan, 2020
Completion date
Dec, 2020
Anticipated
Primary completion date
Nov, 2020
Anticipated
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Not accepted
Enrollment
48 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
experimental: Basis
placebo comparator: Placebo
Interventions
Nicotinamide Riboside and Pterostilbene
Placebo
Primary outcome measure
Central contacts
Locations
Penn Presbyterian Medical Center
Recruiting
Philadelphia, Pennsylvania, United States, 19104
Contacts
Sponsor
Elysium Health
Last update posted
Jan 6, 2020
Last verified
Jan, 2020
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Elysium Health on 2020-01-06.